Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Diabetes

  Free Subscription


Articles published in Metabolism

Retrieve available abstracts of 145 articles:
HTML format



Single Articles


    July 2021
  1. CHEN J, Zhang Q, Liu D, Liu Z, et al
    Exosomes: advances, development and potential therapeutic strategies in diabetic nephropathy.
    Metabolism. 2021 Jul 1:154834. doi: 10.1016/j.metabol.2021.154834.
    PubMed     Abstract available


    June 2021
  2. PRANATA R, Henrina J, Raffaello WM, Lawrensia S, et al
    Diabetes and COVID-19: The Past, The Present, and The Future.
    Metabolism. 2021 Jun 10:154814. doi: 10.1016/j.metabol.2021.154814.
    PubMed     Abstract available


  3. LORETELLI C, Rocchio F, D'Addio F, Nasr MB, et al
    The IL-8-CXCR1/2 axis contributes to diabetic kidney disease.
    Metabolism. 2021 Jun 4:154804. doi: 10.1016/j.metabol.2021.154804.
    PubMed     Abstract available


  4. DING Y, Li G, Zhou Z, Deng T, et al
    Molecular mechanisms underlying hepatitis C virus infection-related diabetes.
    Metabolism. 2021 Jun 3:154802. doi: 10.1016/j.metabol.2021.154802.
    PubMed     Abstract available


  5. TESSIER CM, Kokkinos A, Mingrone G, Koliaki C, et al
    COVID-19 editorial: mechanistic links and therapeutic challenges for metabolic diseases one year into the COVID-19 pandemic.
    Metabolism. 2021;119:154769.
    PubMed    


  6. MUZUROVIC E, Mikhailidis DP, Mantzoros C
    Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.
    Metabolism. 2021;119:154770.
    PubMed     Abstract available


  7. LAMPRINOU A, Willmann C, Machann J, Schick F, et al
    Determinants of hepatic insulin clearance - Results from a Mendelian Randomization study.
    Metabolism. 2021;119:154776.
    PubMed     Abstract available


    May 2021
  8. PRATTICHIZZO F, de Candia P, Ceriello A
    Diabetes and kidney disease: emphasis on treatment with SGLT-2 inhibitors and GLP-1 receptor agonists.
    Metabolism. 2021 May 21:154799. doi: 10.1016/j.metabol.2021.154799.
    PubMed     Abstract available


  9. JANSSEN AWM, Stienstra R, Jaeger M, van Gool AJ, et al
    Understanding the increased risk of infections in diabetes: innate and adaptive immune responses in type 1 diabetes.
    Metabolism. 2021 May 7:154795. doi: 10.1016/j.metabol.2021.154795.
    PubMed     Abstract available


  10. CATALDO LR, Vishnu N, Singh T, Bertonnier-Brouty L, et al
    The MafA-target gene PPP1R1A regulates GLP1R-mediated amplification of glucose-stimulated insulin secretion in beta-cells.
    Metabolism. 2021;118:154734.
    PubMed     Abstract available


  11. SALGADO JV, Goes MA, Salgado Filho N
    FGF21 and Chronic Kidney Disease.
    Metabolism. 2021;118:154738.
    PubMed     Abstract available


    April 2021
  12. RETNAKARAN R
    Diabetes in Pregnancy 100 Years after the Discovery of Insulin: Hot Topics and Open Questions to be Addressed in the Coming Years.
    Metabolism. 2021 Apr 7:154772. doi: 10.1016/j.metabol.2021.154772.
    PubMed     Abstract available


  13. ZHAO T, Wang J, Chen Y, Wang S, et al
    Antiallergic drug Mebhydrolin ameliorates glucose homeostasis in type 2 diabetic mice by functioning as a selective FXR antagonist.
    Metabolism. 2021 Apr 5:154771. doi: 10.1016/j.metabol.2021.154771.
    PubMed     Abstract available


  14. HUERTA GUEVARA AP, McGowan SJ, Kazantzis M, Stallons TR, et al
    Increased insulin sensitivity and diminished pancreatic beta-cell function in DNA repair deficient Ercc1(d/-) mice.
    Metabolism. 2021;117:154711.
    PubMed     Abstract available


  15. LIU Z, Zhu H, Ma Y, Tang Z, et al
    AGEs exacerbates coronary microvascular dysfunction in NoCAD by activating endoplasmic reticulum stress-mediated PERK signaling pathway.
    Metabolism. 2021;117:154710.
    PubMed     Abstract available


  16. TOBIAS DK, Mora S, Verma S, Billia F, et al
    Fasting status and metabolic health in relation to plasma branched chain amino acid concentrations in women.
    Metabolism. 2021;117:154391.
    PubMed     Abstract available


    March 2021
  17. XU X, Dong Y, Ma N, Kong W, et al
    MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice.
    Metabolism. 2021 Mar 25:154768. doi: 10.1016/j.metabol.2021.154768.
    PubMed     Abstract available


  18. CIARDULLO S, Perseghin G
    Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes.
    Metabolism. 2021 Mar 11:154752. doi: 10.1016/j.metabol.2021.154752.
    PubMed     Abstract available


  19. WU M, Yang Z, Zhang C, Shi Y, et al
    Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Metabolism. 2021 Mar 3:154748. doi: 10.1016/j.metabol.2021.154748.
    PubMed     Abstract available


  20. STEVANOVIC-SILVA J, Beleza J, Coxito P, Pereira S, et al
    Maternal high-fat high-sucrose diet and gestational exercise modulate hepatic fat accumulation and liver mitochondrial respiratory capacity in mothers and male offspring.
    Metabolism. 2021;116:154704.
    PubMed     Abstract available


  21. LI X, Jiang Y, Sun X, Wu Y, et al
    METTL3 is required for maintaining beta-cell function.
    Metabolism. 2021;116:154702.
    PubMed     Abstract available


  22. AHN J, Koh J, Kim D, Kim G, et al
    Mean and visit-to-visit variability of glycemia and left ventricular diastolic dysfunction: A longitudinal analysis of 3025 adults with serial echocardiography.
    Metabolism. 2021;116:154451.
    PubMed     Abstract available


    February 2021
  23. WANG H, Huang X, Xu P, Liu X, et al
    Apolipoprotein C3 aggravates diabetic nephropathy in type 1 diabetes by activating the renal TLR2/NF-kappaB pathway.
    Metabolism. 2021 Feb 24:154740. doi: 10.1016/j.metabol.2021.154740.
    PubMed     Abstract available


  24. POLYZOS SA, Mantzoros CS
    Diabetes mellitus: 100 years since the discovery of insulin.
    Metabolism. 2021 Feb 18:154737. doi: 10.1016/j.metabol.2021.154737.
    PubMed     Abstract available


  25. KARLSSON HKR, Kasahara A, Ikeda M, Chibalin A, et al
    Quantitative Phosphoproteomic Analysis of IRS1 in Skeletal Muscle from Men with Normal Glucose Tolerance or Type 2 Diabetes: A Case-Control Study.
    Metabolism. 2021 Feb 10:154726. doi: 10.1016/j.metabol.2021.154726.
    PubMed     Abstract available


  26. AHN M, Oh E, McCown EM, Wang X, et al
    A requirement for PAK1 to support mitochondrial function and maintain cellular redox balance via electron transport chain proteins to prevent beta-cell apoptosis.
    Metabolism. 2021;115:154431.
    PubMed     Abstract available


    January 2021
  27. YANG G, Wei J, Liu P, Zhang Q, et al
    Role of the gut microbiota in type 2 diabetes and related diseases.
    Metabolism. 2021 Jan 23:154712. doi: 10.1016/j.metabol.2021.154712.
    PubMed     Abstract available


  28. ANGELIDI AM, Kokkinos A, Katechaki E, Ros E, et al
    Mediterranean diet as a nutritional approach for COVID-19.
    Metabolism. 2021;114:154407.
    PubMed    


  29. CINTI F, Mezza T, Severi I, Suleiman M, et al
    Noradrenergic fibers are associated with beta-cell dedifferentiation and impaired beta-cell function in humans.
    Metabolism. 2021;114:154414.
    PubMed     Abstract available


  30. WANG X, Chen S, He J, Chen W, et al
    Histone methyltransferases G9a mediated lipid-induced M1 macrophage polarization through negatively regulating CD36.
    Metabolism. 2021;114:154404.
    PubMed     Abstract available


    December 2020
  31. SOTOMAYOR CG, Oskooei SS, Bustos NI, Nolte IM, et al
    Serum Uric Acid is Associated with Increased Risk of Posttransplantation Diabetes in Kidney Transplant Recipients: A Prospective Cohort Study.
    Metabolism. 2020 Dec 11:154465. doi: 10.1016/j.metabol.2020.154465.
    PubMed     Abstract available


    November 2020
  32. BLOMDAHL J, Nasr P, Ekstedt M, Kechagias S, et al
    Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus.
    Metabolism. 2020 Nov 24:154439. doi: 10.1016/j.metabol.2020.154439.
    PubMed     Abstract available


  33. JI D, Zhang M, Qin E, Zhang L, et al
    Obesity, Diabetes, Non-alcoholic Fatty Liver Disease and Metabolic Dysfunction Associated Fatty Liver Disease are Proinflammatory Hypercoagulable States associated with Severe Disease and Thrombosis in Covid-19.
    Metabolism. 2020 Nov 18:154437. doi: 10.1016/j.metabol.2020.154437.
    PubMed    


  34. QU J, Qu HQ, Bradfield J, Glessner J, et al
    Association of DLL1 with type 1 diabetes in patients characterized by low polygenic risk score.
    Metabolism. 2020 Nov 3:154418. doi: 10.1016/j.metabol.2020.154418.
    PubMed     Abstract available


  35. MOIN ASM, Al-Qaissi A, Sathyapalan T, Atkin SL, et al
    Do biomarkers of COVID-19 severity simply reflect a stress response in type 2 diabetes: biomarker response to hypoglycemia.
    Metabolism. 2020 Nov 3:154417. doi: 10.1016/j.metabol.2020.154417.
    PubMed    


    October 2020
  36. GRESPAN E, Giorgino T, Natali A, Ferrannini E, et al
    Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetes.
    Metabolism. 2020 Oct 30:154415. doi: 10.1016/j.metabol.2020.154415.
    PubMed     Abstract available


  37. FIORENTINO TV, Monroy A, Kamath S, Sotero R, et al
    Pioglitazone corrects dysregulation of skeletal muscle mitochondrial proteins involved in ATP synthesis in type 2 diabetes.
    Metabolism. 2020 Oct 30:154416. doi: 10.1016/j.metabol.2020.154416.
    PubMed     Abstract available


  38. QIU D, Nikita D, Zhang L, Deng J, et al
    ICAM-1 deletion delays the repair process in aging diabetic mice.
    Metabolism. 2020;114:154412.
    PubMed     Abstract available


  39. OTOMO H, Nara M, Kato S, Shimizu T, et al
    Sodium-glucose cotransporter 2 inhibition attenuates protein overload in renal proximal tubule via suppression of megalin O-GlcNacylation in progressive diabetic nephropathy.
    Metabolism. 2020 Oct 15:154405. doi: 10.1016/j.metabol.2020.154405.
    PubMed     Abstract available


  40. SHIN SJ, Chen CH, Kuo WC, Chan HC, et al
    Disruption of retinoid homeostasis induces RBP4 overproduction in diabetes: O-GlcNAcylation involved.
    Metabolism. 2020;113:154403.
    PubMed     Abstract available


  41. ATANES P, Lee V, Huang GC, Persaud SJ, et al
    The role of the CCL25-CCR9 axis in beta-cell function: potential for therapeutic intervention in type 2 diabetes.
    Metabolism. 2020 Oct 12:154394. doi: 10.1016/j.metabol.2020.154394.
    PubMed     Abstract available


  42. LI Y, Li J, Zhao C, Yang L, et al
    Hyperglycemia-reduced NAD(+) biosynthesis impairs corneal epithelial wound healing in diabetic mice.
    Metabolism. 2020 Oct 11:154402. doi: 10.1016/j.metabol.2020.154402.
    PubMed     Abstract available


  43. MISHRA RC, Kyle BD, Kendrick DJ, Svystonyuk D, et al
    KCa channel activation normalizes endothelial function in Type 2 Diabetic resistance arteries by improving intracellular Ca(2+) mobilization.
    Metabolism. 2020 Oct 8:154390. doi: 10.1016/j.metabol.2020.154390.
    PubMed     Abstract available


  44. MANTOVANI A, Scorletti E, Mosca A, Alisi A, et al
    Complications, morbidity and mortality of nonalcoholic fatty liver disease.
    Metabolism. 2020;111S:154170.
    PubMed     Abstract available


    September 2020
  45. MOIN ASM, Sathyapalan T, Atkin SL, Butler AE, et al
    M2 macrophage markers in type 2 diabetes.
    Metabolism. 2020 Sep 16:154374. doi: 10.1016/j.metabol.2020.154374.
    PubMed    


  46. SONG D, Yang Q, Jiang X, Shan A, et al
    YY1 deficiency in beta-cells leads to mitochondrial dysfunction and diabetes in mice.
    Metabolism. 2020 Sep 8:154353. doi: 10.1016/j.metabol.2020.154353.
    PubMed     Abstract available


  47. PRATTICHIZZO F, de Candia P, De Nigris V, Nicolucci A, et al
    Legacy effect of intensive glucose control on major adverse cardiovascular outcome: Systematic review and meta-analyses of trials according to different scenarios.
    Metabolism. 2020;110:154308.
    PubMed     Abstract available


  48. STEFANOVSKI D, Vellanki P, Smiley-Byrd DD, Umpierrez GE, et al
    Population insulin sensitivity from sparsely sampled oral glucose tolerance tests.
    Metabolism. 2020;110:154298.
    PubMed     Abstract available


  49. PANAGIOTAKOU A, Yavropoulou M, Nasiri-Ansari N, Makras P, et al
    Extra-skeletal effects of bisphosphonates.
    Metabolism. 2020;110:154264.
    PubMed     Abstract available


    August 2020
  50. HAMER M, Gale CR, Batty GD
    Diabetes, glycaemic control, and risk of COVID-19 hospitalisation: population-based, prospective cohort study.
    Metabolism. 2020 Aug 21:154344. doi: 10.1016/j.metabol.2020.154344.
    PubMed     Abstract available


  51. SUN Y, Zhou S, Shi Y, Zhou Y, et al
    Inhibition of miR-153, an IL-1beta-responsive miRNA, prevents beta cell failure and inflammation-associated diabetes.
    Metabolism. 2020 Aug 11:154335. doi: 10.1016/j.metabol.2020.154335.
    PubMed     Abstract available


  52. WILSON C, Zhang X, Lee MD, MacDonald M, et al
    Disrupted Endothelial Cell Heterogeneity and Network Organization Impair Vascular Function in Prediabetic Obesity.
    Metabolism. 2020 Aug 10:154340. doi: 10.1016/j.metabol.2020.154340.
    PubMed     Abstract available


  53. LIU X, Xu C, Xu L, Li X, et al
    Empagliflozin improves diabetic renal tubular injury by alleviating mitochondrial fission via AMPK/SP1/PGAM5 pathway.
    Metabolism. 2020;111:154334.
    PubMed     Abstract available


  54. LOKAU J, Waetzig GH, Rose-John S, Garbers C, et al
    Letter to the Editor: Non-specific effects resulting from use of tocilizumab in mice.
    Metabolism. 2020;109:154281.
    PubMed    


  55. ZHOU JB, Tang X, Han M, Yang J, et al
    Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis.
    Metabolism. 2020;109:154265.
    PubMed     Abstract available


  56. JAMES D, Umekwe N, Edeoga C, Nyenwe E, et al
    Multi-year reproducibility of hyperinsulinemic euglycemic clamp-derived insulin sensitivity in free-living adults: Association with incident prediabetes in the POP-ABC study.
    Metabolism. 2020;109:154263.
    PubMed     Abstract available


    July 2020
  57. WEI R, Cui X, Feng J, Gu L, et al
    Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
    Metabolism. 2020 Jul 23:154324. doi: 10.1016/j.metabol.2020.154324.
    PubMed     Abstract available


  58. KONG W, Zhang J, Xu Y, Li L, et al
    Letter to the Editor: Fasting plasma glucose associated with mortality rate in T2DM patients with COVID-19 infection.
    Metabolism. 2020;108:154255.
    PubMed    


    June 2020
  59. MARRANO N, Biondi G, Cignarelli A, Perrini S, et al
    Functional loss of pancreatic islets in type 2 diabetes: how can we halt it?
    Metabolism. 2020 Jun 26:154304. doi: 10.1016/j.metabol.2020.154304.
    PubMed     Abstract available


  60. CHAMORRO-PAREJA N, Parthasarathy S, Annam J, Hoffman J, et al
    Unexpected high mortality in COVID-19 and diabetic ketoacidosis.
    Metabolism. 2020 Jun 23:154301. doi: 10.1016/j.metabol.2020.154301.
    PubMed    


  61. DEWIDAR B, Kahl S, Pafili K, Roden M, et al
    Metabolic liver disease in diabetes - from mechanisms to clinical trials.
    Metabolism. 2020 Jun 19:154299. doi: 10.1016/j.metabol.2020.154299.
    PubMed     Abstract available


  62. STOIAN AP, Sachinidis A, Stoica RA, Nikolic D, et al
    The efficacy and safety of Dipeptyl Peptidase-4 inhibitors compared to other Oral glucose-lowering medications in the treatment of type 2 diabetes.
    Metabolism. 2020 Jun 15:154295. doi: 10.1016/j.metabol.2020.154295.
    PubMed     Abstract available


  63. DAVIES MJ, Bianchi C, Del Prato S
    Use of incretin-based medications: what do current international recommendations suggest with respect to GLP-1 receptor agonists and DPP-4 inhibitors?
    Metabolism. 2020;107:154242.
    PubMed     Abstract available


    May 2020
  64. YANG T, Heng C, Zhou Y, Hu Y, et al
    Targeting mammalian serine/threonine-protein kinase 4 through yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis.
    Metabolism. 2020 May 3:154258. doi: 10.1016/j.metabol.2020.154258.
    PubMed     Abstract available


  65. MORIERI ML, Rigato M, Frison V, Simioni N, et al
    Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studies.
    Metabolism. 2020;106:154190.
    PubMed     Abstract available


    April 2020
  66. MEANS C
    Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy.
    Metabolism. 2020 Apr 28:154254. doi: 10.1016/j.metabol.2020.154254.
    PubMed    


  67. MUKHTAZR S, Mukhtar S
    Mental Health and Psychological Distress in People with Diabetes during COVID-19.
    Metabolism. 2020 Apr 23:154248. doi: 10.1016/j.metabol.2020.154248.
    PubMed    


  68. ANGELIDI AM, Belanger MJ, Mantzoros CS
    COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next.
    Metabolism. 2020 Apr 19:154245. doi: 10.1016/j.metabol.2020.154245.
    PubMed    


  69. GUO D, Mizukami H, Osonoi S, Takahashi K, et al
    Beneficial effects of combination therapy of canagliflozin and teneligliptin on diabetic polyneuropathy and beta-cell volume density in spontaneously type 2 diabetic Goto-Kakizaki rats.
    Metabolism. 2020 Apr 14:154232. doi: 10.1016/j.metabol.2020.154232.
    PubMed     Abstract available


  70. KLONOFF DC, Umpierrez GE
    COVID-19 in patients with diabetes: risk factors that increase morbidity.
    Metabolism. 2020 Apr 7:154224. doi: 10.1016/j.metabol.2020.154224.
    PubMed    


  71. MENGOZZI A, Trico D, Nesti L, Petrie J, et al
    Disruption of fasting and post-load glucose homeostasis are largely independent and sustained by distinct and early major beta-cell function defects: a cross-sectional and longitudinal analysis of the Relationship between Insulin Sensitivity and Cardi
    Metabolism. 2020;105:154185.
    PubMed     Abstract available


    March 2020
  72. VAN CAMPENHOUT S, Tilleman L, Lefere S, Vandierendonck A, et al
    Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model.
    Metabolism. 2020 Mar 31:154220. doi: 10.1016/j.metabol.2020.154220.
    PubMed     Abstract available


  73. GAR C, Rottenkolber M, Haenelt M, Potzel AL, et al
    Altered metabolic and hormonal responses to moderate exercise in overweight/obesity.
    Metabolism. 2020 Mar 30:154219. doi: 10.1016/j.metabol.2020.154219.
    PubMed     Abstract available


  74. KATSIKI N, Ferrannini E, Mantzoros C
    New American Diabetes Association (ADA)/European Association for the Study of diabetes (EASD) guidelines for the pharmacotherapy of type 2 diabetes: placing them into a practicing physician's perspective.
    Metabolism. 2020 Mar 25:154218. doi: 10.1016/j.metabol.2020.154218.
    PubMed    


  75. ZHOU J, Tan J
    Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China.
    Metabolism. 2020;107:154216.
    PubMed    


  76. HILL MA, Mantzoros C, Sowers JR
    Commentary: COVID-19 in Patients with Diabetes.
    Metabolism. 2020 Mar 24:154217. doi: 10.1016/j.metabol.2020.154217.
    PubMed    


    February 2020
  77. MCCULLOCH LJ, Bramwell LR, Knight B, Kos K, et al
    Circulating and tissue specific transcription of angiopoietin-like protein 4 in human Type 2 diabetes.
    Metabolism. 2020 Feb 26:154192. doi: 10.1016/j.metabol.2020.154192.
    PubMed     Abstract available


  78. WEI X, Wei X, Lu Z, Li L, et al
    Activation of TRPV1 channel antagonizes diabetic nephropathy through inhibiting endoplasmic reticulum-mitochondria contact in podocytes.
    Metabolism. 2020 Feb 12:154182. doi: 10.1016/j.metabol.2020.154182.
    PubMed     Abstract available


  79. ADAMS JD, Man CD, Laurenti MC, Andrade MDH, et al
    Fasting glucagon concentrations are associated with longitudinal decline of beta-cell function in non-diabetic humans.
    Metabolism. 2020 Feb 8:154175. doi: 10.1016/j.metabol.2020.154175.
    PubMed     Abstract available


    January 2020
  80. WANG P, Yang X, Zhang Z, Song J, et al
    Corrigendum to "Depletion of NAD pool contributes to impairment of endothelial progenitor cell mobilization in diabetes" [Metab Clin Exp 65 (2016) 852-862].
    Metabolism. 2020;104:154139.
    PubMed    


  81. HSU YH, Chen YC, Chen YW, Chiu TH, et al
    Far-infrared radiation prevents decline in beta-cell mass and function in diabetic mice via the mitochondria-mediated Sirtuin1 pathway.
    Metabolism. 2020 Jan 9:154143. doi: 10.1016/j.metabol.2020.154143.
    PubMed     Abstract available


  82. VUILLEUMIER NC, Gauthier BR
    Time for a paradigm shift in treating type 1 diabetes mellitus: coupling inflammation to islet Regeneration.
    Metabolism. 2020 Jan 2:154137. doi: 10.1016/j.metabol.2020.154137.
    PubMed     Abstract available


    December 2019
  83. GUARDADO-MENDOZA R, Salazar-Lopez SS, de la Luz Alvarez-Canales MF, Vazquez DF, et al
    The combination of Linagliptin, Metformin and Lifestyle Modification to prevent Type 2 Diabetes (PRELLIM). A randomized clinical trial.
    Metabolism. 2019 Dec 27:154054. doi: 10.1016/j.metabol.2019.154054.
    PubMed     Abstract available


  84. RANJBAR G, Mikhailidis DP, Sahebkar A
    Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!
    Metabolism. 2019;101:154001.
    PubMed     Abstract available


  85. KITAZAWA M, Fujihara K, Osawa T, Yamamoto M, et al
    Risk of coronary artery disease according to glucose abnormality status and prior coronary artery disease in Japanese men.
    Metabolism. 2019;101:153991.
    PubMed     Abstract available


    November 2019
  86. CHAVEZ-TALAVERA O, Wargny M, Pichelin M, Descat A, et al
    Bile acids associate with glucose metabolism, but do not predict conversion from impaired fasting glucose to diabetes.
    Metabolism. 2019 Nov 27:154042. doi: 10.1016/j.metabol.2019.154042.
    PubMed     Abstract available


  87. NAUCK MA
    The rollercoaster history of using physiological and pharmacological properties of incretin hormones to develop diabetes medications with a convincing benefit-risk relationship.
    Metabolism. 2019 Nov 27:154031. doi: 10.1016/j.metabol.2019.154031.
    PubMed    


  88. XU BH, Sheng J, You YK, Huang XR, et al
    Deletion of Smad3 prevents renal fibrosis and inflammation in type 2 diabetic nephropathy.
    Metabolism. 2019 Nov 14:154013. doi: 10.1016/j.metabol.2019.154013.
    PubMed     Abstract available


  89. SUN Y, Zhou S, Guo H, Zhang J, et al
    Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function.
    Metabolism. 2019 Nov 7:154002. doi: 10.1016/j.metabol.2019.154002.
    PubMed     Abstract available


  90. TREMBLAY J, Hamet P
    Environmental and genetic contributions to diabetes.
    Metabolism. 2019;100S:153952.
    PubMed     Abstract available


    October 2019
  91. FUKUHARA S, Yasukawa K, Sato M, Ikeda H, et al
    Clinical usefulness of human serum nonmercaptalbumin to mercaptalbumin ratio as a biomarker for diabetic complications and disability in activities of daily living in elderly patients with diabetes.
    Metabolism. 2019 Oct 28:153995. doi: 10.1016/j.metabol.2019.153995.
    PubMed     Abstract available


  92. FARNGREN J, Ahren B
    Incretin-based medications (GLP-1 receptor agonists, DPP-4 inhibitors) as a means to avoid hypoglycaemic episodes.
    Metabolism. 2019;99:25-31.
    PubMed     Abstract available


    August 2019
  93. SUN Y, Gao Y, Chen J, Sun H, et al
    Evidence mapping of recommendations on diagnosis and therapeutic strategies for diabetes foot: an international review of 22 guidelines.
    Metabolism. 2019 Aug 5:153956. doi: 10.1016/j.metabol.2019.153956.
    PubMed     Abstract available


    July 2019
  94. JIANG Z, Zhou J, Li T, Tian M, et al
    Hepatic deficiency of Poldip2 in type 2 diabetes dampens lipid and glucose homeostasis.
    Metabolism. 2019 Jul 25:153948. doi: 10.1016/j.metabol.2019.153948.
    PubMed     Abstract available


  95. HUANG S, Ma S, Ning M, Yang W, et al
    TGR5 agonist ameliorates insulin resistance in the skeletal muscles and improves glucose homeostasis in diabetic mice.
    Metabolism. 2019 Jul 8. pii: S0026-0495(19)30136.
    PubMed     Abstract available


    June 2019
  96. ALEXOPOULOS AS, Buse JB
    Initial injectable therapy in type 2 diabetes: key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin.
    Metabolism. 2019 Jun 27. pii: S0026-0495(19)30127.
    PubMed     Abstract available


    May 2019
  97. QUICLET C, Dittberner N, Gassler A, Stadion M, et al
    Pancreatic adipocytes mediate hypersecretion of insulin in diabetes-susceptible mice.
    Metabolism. 2019 May 17. pii: S0026-0495(19)30093.
    PubMed     Abstract available


    April 2019
  98. YANG T, Shu F, Yang H, Heng C, et al
    YY1:a novel therapeutic target for diabetic nephropathy orchestrated renal fibrosis.
    Metabolism. 2019 Apr 25. pii: S0026-0495(19)30085.
    PubMed     Abstract available


  99. ZENG Y, Mtintsilana A, Goedecke JH, Micklesfield LK, et al
    Alterations in the metabolism of phospholipids, bile acids and branched-chain amino acids predicts development of type 2 diabetes in black south African women: a prospective cohort study.
    Metabolism. 2019 Apr 4. pii: S0026-0495(19)30067.
    PubMed     Abstract available


  100. VAN NIEROP FS, de Jonge C, Kulik W, Bouvy N, et al
    Duodenal-jejunal lining increases postprandial unconjugated bile acid responses and disrupts the bile acid-FXR-FGF19 axis in humans.
    Metabolism. 2019;93:25-32.
    PubMed     Abstract available


    March 2019
  101. GILARDI F, Winkler C, Quignodon L, Diserens JG, et al
    Systemic PPARgamma deletion in mice provokes lipoatrophy, organomegaly, severe type 2 diabetes and metabolic inflexibility.
    Metabolism. 2019 Mar 13. pii: S0026-0495(19)30051.
    PubMed     Abstract available


  102. KOOPMAN ADM, Beulens JW, Voerman E, Rauh SP, et al
    GAD65 antibodies and incident type 2 Diabetes mellitus.
    Metabolism. 2019 Mar 7. pii: S0026-0495(19)30049.
    PubMed     Abstract available


    February 2019
  103. PERADZE N, Farr OM, Mantzoros CS
    Research developments in metabolism 2018.
    Metabolism. 2019;91:70-79.
    PubMed    


    January 2019
  104. ZHOU Z, Sun B, Huang S, Jia W, et al
    The tRNA-associated dysregulation in diabetes mellitus.
    Metabolism. 2019 Jan 31. pii: S0026-0495(19)30032.
    PubMed     Abstract available


  105. KIM MJ, Kim MN, Min SH, Ham DS, et al
    Specific PERK inhibitors enhanced glucose-stimulated insulin secretion in a mouse model of type 2 diabetes.
    Metabolism. 2019 Jan 4. pii: S0026-0495(18)30267.
    PubMed     Abstract available


  106. AHMAD A, Ali T, Kim MW, Khan A, et al
    Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARalpha signaling in ob/ob and db/db transgenic mouse models.
    Metabolism. 2019;90:31-43.
    PubMed     Abstract available


    December 2018
  107. SHAH M, Laurenti MC, Man CD, Ma J, et al
    Contribution of endogenous glucagon-like Peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after roux-en-Y gastric bypass (RYGB).
    Metabolism. 2018 Dec 23. pii: S0026-0495(18)30265.
    PubMed     Abstract available


    November 2018
  108. LAYTON J, Powe C, Allard C, Battista MC, et al
    Maternal lipid profile differs by gestational diabetes physiologic subtype.
    Metabolism. 2018 Nov 20. pii: S0026-0495(18)30247.
    PubMed     Abstract available


  109. SUAREZ AL
    Burden of cancer attributable to obesity, type 2 diabetes and associated risk factors.
    Metabolism. 2018 Nov 6. pii: S0026-0495(18)30231.
    PubMed     Abstract available


    October 2018
  110. PATH G, Perakakis N, Mantzoros CS, Seufert J, et al
    Stem cells in the treatment of diabetes mellitus - focus on mesenchymal stem cells.
    Metabolism. 2018 Oct 17. pii: S0026-0495(18)30215.
    PubMed     Abstract available


  111. YARIBEYGI H, Katsiki N, Behnam B, Iranpanah H, et al
    MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment.
    Metabolism. 2018;87:48-55.
    PubMed     Abstract available


    May 2018
  112. TSENG CH
    Metformin and risk of developing nasopharyngeal cancer in patients with type 2 diabetes mellitus.
    Metabolism. 2018 May 2. pii: S0026-0495(18)30115.
    PubMed     Abstract available


  113. YANG P, Huang T, Xu G
    Corrigendum to "The novel mineralocorticoid receptor antagonist finerenone in diabetic kidney disease: Progress and challenges" [Metabolism 65 (2016) 1342-1349].
    Metabolism. 2018;82:124.
    PubMed    


    April 2018
  114. KINTIRAKI E, Goulis DG
    Gestational Diabetes Mellitus: multi-disciplinary treatment approaches.
    Metabolism. 2018 Apr 5. pii: S0026-0495(18)30097.
    PubMed     Abstract available


    March 2018
  115. DOKE T, Ishimoto T, Hayasaki T, Ikeda S, et al
    Lacking Ketohexokinase-A Exacerbates Renal Injury in Streptozotocin-induced Diabetic Mice.
    Metabolism. 2018 Mar 28. pii: S0026-0495(18)30092.
    PubMed     Abstract available


  116. BASOLO A, Burkholder J, Osgood K, Graham A, et al
    Exenatide has a Pronounced Effect on Energy Intake but not Energy Expenditure in Non-Diabetic Subjects with Obesity: A Randomized, Double-blind, Placebo-Controlled Trial.
    Metabolism. 2018 Mar 26. pii: S0026-0495(18)30089.
    PubMed     Abstract available


  117. ZHENG T, Liu H, Qin L, Chen B, et al
    Oxidative Stress-Mediated Influence of Plasma DPP4 Activity to BDNF Ratio on Mild Cognitive Impairment in Elderly Type 2 Diabetic Patients: Results From the GDMD Study in China.
    Metabolism. 2018 Mar 20. pii: S0026-0495(18)30086.
    PubMed     Abstract available


  118. QIU T, Li M, Tanner MA, Yang Y, et al
    Depletion of dendritic cells in perivascular adipose tissue improves arterial relaxation responses in type 2 diabetic mice.
    Metabolism. 2018 Mar 9. pii: S0026-0495(18)30068.
    PubMed     Abstract available


  119. CHO YY, Cho SI
    Metformin combined with dipeptidyl peptidase-4 inhibitors or metformin combined with sulfonylureas in patients with type 2 diabetes: A real world analysis of the South Korean national cohort.
    Metabolism. 2018 Mar 9. pii: S0026-0495(18)30081.
    PubMed     Abstract available


  120. REUTRAKUL S, Van Cauter E
    Sleep influences on obesity, insulin resistance, and risk of type 2 diabetes.
    Metabolism. 2018 Mar 3. pii: S0026-0495(18)30063.
    PubMed     Abstract available


    February 2018
  121. CHOI SR, Lim JH, Kim MY, Kim EN, et al
    Adiponectin Receptor Agonist AdipoRon Decreased Ceramide, and Lipotoxicity, and Ameliorated Diabetic Nephropathy.
    Metabolism. 2018 Feb 17. pii: S0026-0495(18)30043.
    PubMed     Abstract available


  122. TIMOTHY GARVEY W, Van Gaal L, Leiter LA, Vijapurkar U, et al
    Effects of Canagliflozin Versus Glimepiride on Adipokines and Inflammatory Biomarkers in Type 2 Diabetes.
    Metabolism. 2018 Feb 13. pii: S0026-0495(18)30041.
    PubMed     Abstract available


  123. LI TC, Li CI, Liu CS, Lin WY, et al
    Development and validation of prediction models for the risks of diabetes-related hospitalization and in-hospital mortality in patients with type 2 diabetes.
    Metabolism. 2018 Feb 13. pii: S0026-0495(18)30042.
    PubMed     Abstract available


  124. KINTIRAKI E, Dipla K, Triantafyllou A, Koletsos N, et al
    Blunted cerebral oxygenation during exercise in women with gestational diabetes mellitus: associations with macrovascular function and cardiovascular risk factors.
    Metabolism. 2018 Feb 1. pii: S0026-0495(18)30015.
    PubMed     Abstract available


    January 2018
  125. HOLINGUE C, Wennberg A, Berger S, Polotsky VY, et al
    Disturbed Sleep and Diabetes: A Potential Nexus of Dementia Risk.
    Metabolism. 2018 Jan 31. pii: S0026-0495(18)30029.
    PubMed     Abstract available


  126. NISHIHAMA K, Yasuma T, Yano Y, D' Alessandro-Gabazza CN, et al
    Anti-apoptotic activity of human matrix Metalloproteinase-2 attenuates diabetes mellitus.
    Metabolism. 2018 Jan 20. pii: S0026-0495(18)30022.
    PubMed     Abstract available


  127. WU R, Liu X, Yin J, Wu H, et al
    IL-6 receptor blockade ameliorates diabetic nephropathy via inhibiting inflammasome in mice.
    Metabolism. 2018 Jan 11. pii: S0026-0495(18)30007.
    PubMed     Abstract available


  128. BROSKEY NT, Obanda DN, Burton JH, Cefalu WT, et al
    Skeletal muscle ceramides and daily fat oxidation in obesity and diabetes.
    Metabolism. 2018 Jan 4. pii: S0026-0495(17)30359.
    PubMed     Abstract available


  129. PASTEL E, Price E, Sjoholm K, McCulloch LJ, et al
    Lysyl oxidase and adipose tissue dysfunction.
    Metabolism. 2018;78:118-127.
    PubMed     Abstract available


    December 2017
  130. SONODA N, Morimoto A, Tatsumi Y, Asayama K, et al
    A prospective study of the impact of diabetes mellitus on restrictive and obstructive lung function impairment: the Saku study.
    Metabolism. 2017 Dec 28. pii: S0026-0495(17)30343.
    PubMed     Abstract available


  131. XIAOYAN Z, Yang W, Wang J, Meng Y, et al
    FAM3 gene family: a promising therapeutical target for NAFLD and type 2 diabetes.
    Metabolism. 2017 Dec 5. pii: S0026-0495(17)30336.
    PubMed     Abstract available


  132. MIZUNO Y, Harada E, Nakagawa H, Morikawa Y, et al
    The diabetic heart utilizes ketone bodies as an energy source.
    Metabolism. 2017;77:65-72.
    PubMed     Abstract available


    November 2017
  133. WU D, Yan ZB, Cheng YG, Zhong MW, et al
    Deactivation of the NLRP3 inflammasome in infiltrating macrophages by duodenal-jejunal bypass surgery mediates improvement of beta cell function in type 2 diabetes.
    Metabolism. 2017 Nov 9. pii: S0026-0495(17)30304.
    PubMed     Abstract available


  134. ZIEGLER D, Strom A, Bonhof G, Puttgen S, et al
    Differential associations of lower cardiac vagal tone with insulin resistance and insulin secretion in recently diagnosed type 1 and type 2 diabetes.
    Metabolism. 2017 Nov 4. pii: S0026-0495(17)30301.
    PubMed     Abstract available


  135. SAHIN-EFE A, Upadhyay J, Ko BJ, Dincer F, et al
    Irisin and Leptin Concentrations in relation to Obesity, and Developing Type 2 Diabetes: a cross sectional and a prospective case-control study nested in the Normative Aging Study.
    Metabolism. 2017 Nov 3. pii: S0026-0495(17)30299.
    PubMed     Abstract available


  136. ITO Y, Hsu MF, Bettaieb A, Koike S, et al
    Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury.
    Metabolism. 2017;76:56-69.
    PubMed     Abstract available


    October 2017
  137. LI LJ, Tan KH, Aris IM, Man REK, et al
    Retinal Vasculature and 5-Year Metabolic Syndrome among Women with Gestational Diabetes Mellitus.
    Metabolism. 2017 Oct 16. pii: S0026-0495(17)30278.
    PubMed     Abstract available


  138. GALLO M, Muscogiuri G, Felicetti F, Faggiano A, et al
    Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes.
    Metabolism. 2017 Oct 6. pii: S0026-0495(17)30265.
    PubMed     Abstract available


  139. GUELFI KJ, Ong MJ, Li S, Wallman KE, et al
    Maternal circulating adipokine profile and insulin resistance in women at high risk of developing gestational diabetes mellitus.
    Metabolism. 2017;75:54-60.
    PubMed     Abstract available


  140. SONDERGAARD E, Johansen RF, Jensen MD, Nielsen S, et al
    Postprandial VLDL-TG metabolism in type 2 diabetes.
    Metabolism. 2017;75:25-35.
    PubMed     Abstract available


    September 2017
  141. CUI X, You L, Zhu L, Wang X, et al
    Change in circulating microRNA profile of obese children indicates future risk of adult diabetes.
    Metabolism. 2017 Sep 28. pii: S0026-0495(17)30250.
    PubMed     Abstract available


  142. SUVITAIVAL T, Bondia-Pons I, Yetukuri L, Poho P, et al
    Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men.
    Metabolism. 2017 Sep 20. pii: S0026-0495(17)30230.
    PubMed     Abstract available


  143. UPADHYAY J, Polyzos SA, Perakakis N, Thakkar B, et al
    Pharmacotherapy of Type 2 Diabetes: An Update.
    Metabolism. 2017 Sep 8. pii: S0026-0495(17)30216.
    PubMed     Abstract available


    August 2017
  144. WANG H, Song Y, Sun S, Gao L, et al
    The association between immunoglobulin concentrations and prediabetes prevalence in a large Chinese cohort.
    Metabolism. 2017;73:77-84.
    PubMed     Abstract available


    July 2017
  145. THOMAS D, Apovian C
    Macrophage functions in lean and obese adipose tissue.
    Metabolism. 2017;72:120-143.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: